ELAB
PMGC Holdings·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 1
Ample Liquidity
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ELAB
Pmgc Holdings Inc.
A modern beauty and skin care product company
Personal care products
06/09/2020
11/21/2023
NASDAQ Stock Exchange
2
12-31
Common stock
120 Newport Center Drive, Ste. 250, Newport Beach, CA 92660
--
PMGC Holdings Inc. was incorporated under the laws of the State of Delaware on June 9, 2020. On December 23, 2024, the reorganization included changing the company name from Elevai Labs Inc. to PMGC Holdings Inc., and moving the company address from Delaware to Nevada. The company is a doctor-provided skin care company focused on modernizing aesthetic skin care products. The company conducts research and development to advance innovative and science-driven topical skin care that complements the medical beauty industry. Since 2022, the company has mainly adopted a business-to-business model to produce and commercialize a new generation of topical skin care products, including Elevai ExosomesTM, a proprietary stem cell-derived product designed to improve the appearance of the skin.
Company Financials
EPS
ELAB has released its 2023 Q3 earnings. EPS was reported at -0.08, versus the expected 0, missing expectations. The chart below visualizes how ELAB has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ELAB has released its 2025 Q3 earnings report, with revenue of 285.95K, reflecting a YoY change of -45.79%, and net profit of -2.59M, showing a YoY change of -72.81%. The Sankey diagram below clearly presents ELAB's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
